candesartan cilexetil has been researched along with Bile Duct Obstruction, Intrahepatic in 1 studies
candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects
Excerpt | Relevance | Reference |
---|---|---|
" To our knowledge, this is the first description of severe hepatotoxicity associated with ductopenia caused by an adverse reaction to candesartan cilexetil." | 1.32 | Candesartan cilexetil-induced severe hepatotoxicity. ( Accetta, MG; Basile, G; Ferrara, T; Gangemi, S; Nicita-Mauro, V; Villari, D, 2003) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Basile, G | 1 |
Villari, D | 1 |
Gangemi, S | 1 |
Ferrara, T | 1 |
Accetta, MG | 1 |
Nicita-Mauro, V | 1 |
1 other study available for candesartan cilexetil and Bile Duct Obstruction, Intrahepatic
Article | Year |
---|---|
Candesartan cilexetil-induced severe hepatotoxicity.
Topics: Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Cholestasis, Intrahepatic; Female; Huma | 2003 |